FOX04-DRI
From $108.00to $630.00
FOXO4-DRI peptide, lyophilized reference standard for in vitro laboratory research.
Volume Tier Pricing · Mix & Match
Combine eligible single vials across catalog items to unlock volume rates.
Add 1 more eligible vial to unlock 12.5% total savings.
Price
$108.00
✓ You save $12.00 (10% total savings vs regular price)
Quantity
In Stock · 100 Units Available
This strength’s Certificate of Analysis isn’t published yet — add to cart will be enabled once the lab report is available.
- Free FedEx 2-Day shipping over $200. Dispatched the same day when ordered before 4 p.m. PT Monday–Friday, or 11 a.m. PT Saturday. Los Angeles and the surrounding area usually arrive the next business day. Shipping details
- Third-party HPLC tested. Every lot ships with a batch-linked certificate of analysis naming the laboratory, the method and the measured result. Browse certificates
- Questions about this material? Message us on WhatsApp +1 (747) 204 9968 or email support@kamresearch.com. Monday–Friday, 8 a.m.–5 p.m. PST.
Certificate of Analysis & Specifications
Documentation will be published once this lot completes third-party analytical release.
Released COA Library
Published Certificates of Analysis for FOX04-DRI. All released analytical records are preserved here. Pending and in-testing lots are reachable only through the QR printed on the vial.
No released certificate for this material yet
Reports appear here once a batch has completed third-party analytical release.
Research Data
Chemical & Structural Identifiers
- Chemical Name (IUPAC)
- D-retro-inverso peptide antagonist of the forkhead box O4 (FOXO4) and tumor suppressor p53 interaction, fused to a cell-penetrating D-retro-inverso Tat sequence.
- CAS Registry Number
- 2249767-45-5
- PubChem CID
- 137700201
- Molecular Formula
- C226H377N83O63
- Molecular Weight
- 5354.91 Da (5358.20 g/mol average)
- Salt / Counter-Ion
- Supplied as a lyophilized trifluoroacetate (CF3COO-) or acetate (CH3COO-) salt.
- Synonyms
- FOXO4-DRI, FOXO4-D-Retro-Inverso, Proxofim, FOXO4-p53 Interfering Peptide.
Analytical & COA Specifications
- Analytical Purity (RP-HPLC)
- ≥ 98.0% area normalization under UV detection at λ = 214 nm and 280 nm (tryptophan detection).
- Identity Confirmation (RP-HPLC RT + UV vs. reference)
- Main peak retention time and UV spectrum conform to the reference standard.
- Physical Characterization
- Dense, white to off-white lyophilized solid cake/powder.
Handling & Stability
Storage. Store dry solid desiccated at -20°C to -80°C, protected from atmospheric moisture and direct light.
Solubility. Soluble in sterile laboratory-grade deionized water (≥ 10 mg/mL), sterile Phosphate-Buffered Saline (PBS, pH 7.4), or sterile dilute 0.1% acetic acid for stock stabilization in in vitro assay applications.
- D-Enantiomeric Stability & Handling: Constructed entirely with D-amino acids in reverse topological sequence, conferring high stability against standard laboratory endopeptidases and carboxypeptidases; aliquot into single-use fractions to eliminate degradation from repeated freeze-thaw cycles.
Mechanism & Literature
Designed to competitively disrupt the protein-protein interaction (PPI) between the forkhead box transcription factor FOXO4 and the tumor suppressor p53. Under baseline conditions in senescent cells, FOXO4 sequesters p53 in the nucleus, repressing apoptotic triggers. FOXO4-DRI binds to the regulatory domain, displacing p53 and permitting its mitochondrial translocation to induce selective caspase-3/7/9-dependent apoptosis.
Cellular Pathways Investigated: Extensively documented in in vitro cellular senescence models (e.g., ionizing radiation-induced or doxorubicin-induced senescent IMR90 human fibroblasts and senescent primary endothelial cells) to evaluate selective senolysis, downregulation of the senescence-associated secretory phenotype (SASP; IL-6, IL-8, MMP-3), and quantification of cell viability ratios between senescent vs. non-senescent control cultures.
References (2)
- Baar, M. P., et al. (2017). Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell, 169(1), 132–147.
- Huang, C. H., et al. (2021). FOXO4-p53 interaction as a mechanistic target in cellular senescence modeling. Biochemical Society Transactions, 49(3), 1187–1197.
Technical Laboratory FAQs
What is the functional design principle behind the D-retro-inverso (DRI) structure of FOXO4-DRI?
The peptide synthesizes the reverse sequence of the native FOXO4 interaction motif using D-enantiomeric amino acids, preserving side-chain spatial topology while eliminating susceptibility to enzymatic cleavage by L-amino acid-specific proteases in cell culture assays.
How does FOXO4-DRI trigger selective apoptosis in senescent cell lines in vitro?
FOXO4-DRI disrupts the endogenous FOXO4-p53 complex in senescent cells, liberating p53 to translocate to the mitochondria, which initiates cytochrome c release and caspase cascade activation without triggering apoptosis in non-senescent cells.
What solvent conditions are recommended for preparing in vitro FOXO4-DRI stock assays?
Sterile deionized water or sterile PBS (pH 7.4) is suitable for standard biological dilutions. For higher-concentration stock preparations, a sterile 0.1% acetic acid vehicle provides enhanced peptide solubility prior to cell culture media integration.
For Research Use Only. Not for human or animal administration. Not intended to diagnose, treat, cure, or prevent any disease. Sold for laboratory research purposes only.